Mind Medicine Inc (MNMD)

Nov 04, 2024

Mind Medicine: Two Pathways Created From One Pipeline Clinical Candidate (NASDAQ:MNMD) - Seeking Alpha

Nov 04, 2024

Oct 31, 2024

Mind Medicine (MindMed) (MNMD) to Release Quarterly Earnings on Thursday - MarketBeat

Oct 31, 2024

Oct 27, 2024

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat

Oct 27, 2024

Oct 24, 2024

MNMDMind Medicine (MindMed) Inc. Common Shares Latest Stock News & Market Updates - StockTitan

Oct 24, 2024

Oct 24, 2024

MindMed to Host Conference Call and Webcast to Discuss Third Quarter 2024 Financial Results and Provide Business Update - The Globe and Mail

Oct 24, 2024

Oct 19, 2024

FDA is said to see “path forward” for ecstasy-based drug (DRUG:NASDAQ) - Seeking Alpha

Oct 19, 2024

Oct 17, 2024

MindMed announces exchange agreement with investors By Investing.com - Investing.com

Oct 17, 2024

Oct 16, 2024

Bright Minds rally ends as psychedelic stocks extend volatility - MSN

Oct 16, 2024

Oct 16, 2024

Bright Minds stock cools amid psychedelic volatility (DRUG:NASDAQ) - Seeking Alpha

Oct 16, 2024

Oct 15, 2024

(MNMD) Investment Analysis and Advice - Stock Traders Daily

Oct 15, 2024

Oct 15, 2024

Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Rating Upgraded by Leerink Partnrs - MarketBeat

Oct 15, 2024

Oct 14, 2024

Mind Medicine (MindMed) (NASDAQ:MNMD) Coverage Initiated at Leerink Partners - MarketBeat

Oct 14, 2024

Oct 12, 2024

Mind Medicine assumed with an Outperform at Leerink - Yahoo Finance

Oct 12, 2024

Oct 05, 2024

Trend Tracker for (MNMD) - Stock Traders Daily

Oct 05, 2024

Oct 02, 2024

"TNT Radio" Jeff Ghaemaghamy on Mind Medicine with Charles Kovess28 January 2024 (Podcast Episode 2024)News - imdb

Oct 02, 2024

Oct 02, 2024

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat

Oct 02, 2024

Oct 01, 2024

MindMed's SWOT analysis: psychedelic stock's potential in anxiety treatment - Investing.com

Oct 01, 2024

Sep 28, 2024

Marshall Wace LLP Has $15.58 Million Stock Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - MarketBeat

Sep 28, 2024

Sep 26, 2024

Mind Medicine's chief medical officer sells shares worth over $41,000 By Investing.com - Investing.com UK

Sep 26, 2024

Sep 25, 2024

MindMed executive sells over $26k in company stock By Investing.com - Investing.com South Africa

Sep 25, 2024

Sep 25, 2024

Mind Medicine's chief medical officer sells shares worth over $41,000 - Investing.com

Sep 25, 2024

Sep 25, 2024

Generalized Anxiety Disorder Pipeline Trends 2024: Clinical Trials, Therapeutic Innovations, MOA, ROA by DelveInsight | Pfizer Inc., GlaxoSmithKline, Eli Lilly and Company, MindMed, VistaGen Pharma - Barchart

Sep 25, 2024

Sep 25, 2024

Rhumbline Advisers Makes New $679,000 Investment in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - MarketBeat

Sep 25, 2024

Sep 24, 2024

Generalized Anxiety Disorder Global Market is Booming Across - openPR

Sep 24, 2024

Sep 24, 2024

(MNMD) Proactive Strategies - Stock Traders Daily

Sep 24, 2024

Sep 20, 2024

Mankind Pharma: Rs 10000 crore fund raise via this routeDetails - ET Now

Sep 20, 2024

Sep 20, 2024

Mankind Pharma to raise up to ₹10,000 crore through NCDs - CNBCTV18

Sep 20, 2024

Sep 20, 2024

Mankind Pharma board approves up to Rs 10,000-crore fund raise via NCDs, CPs - Moneycontrol

Sep 20, 2024

Sep 20, 2024

Mount Sinai Opens New Psychedelic Research Center in NYC - Mirage News

Sep 20, 2024

Sep 19, 2024

Psychedelic research at a crossroads - Science

Sep 19, 2024

Sep 19, 2024

Director GRYSKA DAVID W acquired 3,500 shares of Mind Medicine Inc [MNMD] - Knox Daily

Sep 19, 2024

Sep 19, 2024

Bank of New York Mellon Corp Buys 203,216 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - MarketBeat

Sep 19, 2024

Sep 18, 2024

Wall Street analysts’ outlook for Mind Medicine Inc (MNMD) - SETE News

Sep 18, 2024

Sep 17, 2024

Examining the Potential Price Growth of Mind Medicine Inc (MNMD) - Knox Daily

Sep 17, 2024

Sep 17, 2024

Long Strange Trip Continues for Psychedelics in PTSD, TRD - Managed Healthcare Executive

Sep 17, 2024

Sep 17, 2024

A closer look at Mind Medicine Inc (MNMD)’s stock price trends - US Post News

Sep 17, 2024

Sep 17, 2024

Mind Medicine (MindMed) (NASDAQ:MNMD) Given New $14.00 Price Target at Canaccord Genuity Group - Defense World

Sep 17, 2024

Sep 16, 2024

Mannkind Corp (MNKD) gets rating Resumed from Leerink Partners - Knox Daily

Sep 16, 2024

Sep 16, 2024

Mind Medicine (MindMed) (NASDAQ:MNMD) PT Lowered to $14.00 at Canaccord Genuity Group - MarketBeat

Sep 16, 2024

Sep 10, 2024

MindMed Issues New Employee Share Options - TipRanks

Sep 10, 2024

Sep 09, 2024

MindMed Announces New Employee Inducement Grants - Business Wire

Sep 09, 2024

Sep 07, 2024

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Average Rating of "Buy" by Analysts - MarketBeat

Sep 07, 2024

Sep 05, 2024

MindMed Showcases Innovation at Investor Events - TipRanks

Sep 05, 2024

Sep 04, 2024

MindMed to Participate in September Investor Conferences - StockTitan

Sep 04, 2024

Sep 02, 2024

Mind Medicine (MindMed) Inc. Expected to Earn Q3 2024 Earnings of ($0.27) Per Share (NASDAQ:MNMD) - MarketBeat

Sep 02, 2024

Aug 29, 2024

Mind Medicine (MindMed) (NASDAQ:MNMD) Price Target Raised to $55.00 - MarketBeat

Aug 29, 2024

Aug 29, 2024

(MNMD) Long Term Investment Analysis - Stock Traders Daily

Aug 29, 2024

Aug 27, 2024

Mind medicine director David Gryska buys $20,930 in company shares By Investing.com - Investing.com Canada

Aug 27, 2024

Aug 26, 2024

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Director Acquires $20,930.00 in Stock - MarketBeat

Aug 26, 2024

Aug 26, 2024

Mind medicine director David Gryska buys $20,930 in company shares - Investing.com India

Aug 26, 2024

Aug 23, 2024

Mind Medicine Inc’s $75 Million Common Shares Offering - Global Legal Chronicle

Aug 23, 2024

Aug 21, 2024

Mind Medicine: Pumping Up The Balance Sheet (Again) (NASDAQ:MNMD) - Seeking Alpha

Aug 21, 2024